Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital Zhejiang UniversityActive in the last 2 years

Lili Lin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8694-7486; OpenAlex author ID A5101636757. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2024: 1 paper · 2025: 2 papers

Papers 3

  1. Clinical Utility of 18Fluorine-Fibroblast Activation Protein Inhibitor-04 Positron Emission Tomography/Computed Tomography in the Evaluation of Pancreatic Duct… Co-author DOI 10.1002/mco2.70136↗
  2. [18F]FAPI- 04 PET/CT for pathologic response assessment in pancreatic cancer patients with systemic treatment. Co-author DOI 10.1007/s00259-025-07271-6↗
  3. 18F-FAPI-04 Outperforms 18F-FDG PET/CT in Clinical Assessments of Patients with Pancreatic Adenocarcinoma. Co-author DOI 10.2967/jnumed.123.266283↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xinhui Su · 3 shared papers, 2024–2025 · strength 0.72
  2. Yafei Zhang · 1 shared paper, 2025 · strength 0.30
  3. Xiang Li · 1 shared paper, 2025 · strength 0.22
  4. Kang Sun · 1 shared paper, 2025 · strength 0.22
  5. Tingbo Liang · 1 shared paper, 2025 · strength 0.22
  6. Xueli Bai · 1 shared paper, 2025 · strength 0.22
  7. Xiang Li · 1 shared paper, 2024 · strength 0.20
  8. Tingbo Liang · 1 shared paper, 2024 · strength 0.20
  9. Xueli Bai · 1 shared paper, 2024 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.